Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 4 49-4, 2001, Pages

  Zhang, Xiaomin ^a   Azhar, Gohar ^a   Chai, Jianyuan ^a   Sheridan, Pamela ^a   Nagano, Koichiro ^a   Brown, Thomas ^a   Yang, Jihong ^a   Khrapko, Konstantin ^a   Borras, Ana M ^a   Lawitts, Joel ^a   Misra, Ravi P ^b   Wei, Jeanne Y ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Hypertrophy; Muscle genes; Serum response element; Signaling; Transcription

Indexed keywords

COLLAGEN; SERUM RESPONSE FACTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIOMYOPATHY; CONTROLLED STUDY; FIBROSIS; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART FUNCTION; HEART MUSCLE CELL; HEART WEIGHT; HISTOLOGY; MOUSE; MUSCLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 6644220044     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.4.h1782     Document Type: Article

References (59)

1. Alberts AS, Geneste O, and Treisman R. Activation of SRF-regulated chromosomal templates by Rho-family GTPases requires a signal that also induces H4 hyperacetylation. Cell 92: 475-487, 1998.
2. Aoki H, Sadoshima J, and Izumo S. Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro. Nat Med 6: 183-188, 2000.
3. Arai M, Alpert NR, MacLennan DH, Barton P, and Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 72: 463-469, 1993.
4. Argentin S, Ardati A, Tremblay S, Lihrmann I, Robitaille L, Drouin J, and Nemer M. Developmental stage-specific regulation of atrial natriuretic factor gene transcription in cardiac cells. Mol Cell Biol 14: 777-790, 1994.
5. Arsenian S, Weinhold B, Oelgeschlager M, Ruther U, and Nordheim A. Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J 17: 6289-6299, 1998.
6. 2+-ATPase (SERCA2) gene. Nucleic Acids Res 26: 1092-1098, 1998.
7. Belaguli NS, Schildmeyer LA, and Schwartz RJ. Organization and myogenic restricted expression of the murine serum response factor gene. A role for autoregulation. J Biol Chem 272: 18222-18231, 1997.
8. Bishopric NH, Jayasena V, and Webster KA. Positive regulation of the skeletal alpha-actin gene by fos and jun in cardiac myocytes. J Biol Chem 267: 25535-25540, 1992.
9. Black BL and Olson EN. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol 14: 167-196, 1998.
10. Burch M and Blair E. The inheritance of hypertrophic cardiomyopathy. Pediatr Cardiol 20: 313-316, 1999.
11. Chien R. Signaling mechanisms for the activation of an embryonic gene program during the hypertrophy of cardiac ventricular muscle. Basic Res Cardiol 87: 49-58, 1992.
12. Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol 80: 15L-25L, 1997.
13. Croissant JD, Kim JH, Eichele G, Goering L, Lough J, Prywes R, and Schwartz RJ. Avian serum response factor expression restricted primarily to muscle cell lineages is required for alpha-actin gene transcription. Dev Biol 177: 250-264, 1996.
14. Culligan KG, Mackey AJ, Finn DM, Maguire PB, and Ohlendieck K. Role of dystrophin isoforms and associated proteins in muscular dystrophy. Int J Mol Med 2: 639-648, 1998.
15. 2+ ATPase of the sarcoplasmic reticulum by a transgenic approach on cardiac contractility. Ann NY Acad Sci 853: 43-48, 1998.
16. Durand JB. Genetic basis of cardiomyopathy. Curr Opin Cardiol 14: 225-229, 1999.
17. Ferlini A, Sewry C, Melis MA, Mateddu A, and Muntoni F. X-linked dilated cardiomyopathy and the dystrophin gene. Neuromuscul Disord 9: 339-346, 1999.
18. Finkel T. Myocyte hypertrophy: the long and winding RhoA'd (Comment). J Clin Invest 103: 1619-1620, 1999.
19. Fisher SA, Walsh K, and Forehand CJ. Characterization of cardiac gene cis-regulatory elements in the early stages of chicken heart morphogenesis. J Mol Cell Cardiol 28: 113-122, 1996.
20. Flesch M, Schiffer F, Zolk O, Pinto Y, Rosenkranz S, Hirth-Dietrich C, Arnold G, Paul M, and Bohm M. Contractile systolic and diastolic dysfunction in renin-induced hypertensive cardiomyopathy. Hypertension 30: 383-391, 1997.
21. Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, and Seidman JG. A mouse model of familial hypertrophic cardiomyopathy. Science 272: 731-734, 1996.
22. Gillespie-Brown J, Fuller SJ, Bogoyevitch MA, Cowley S, and Sugden PH. The mitogen-activated protein kinase kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular cardiomyocytes. J BM Chem 270: 28092-28096, 1995.
23. Gustafson TA and Kedes L. Identification of multiple proteins that interact with functional regions of the human cardiac alpha-actin promoter. Mol Cell Biol 9: 3269-3283, 1989.
24. Henderson SA, Spencer M, Sen A, Kumar C, Siddiqui MA, and Chien KR. Structure, organization, and expression of the rat cardiac myosin light chain-2 gene. Identification of a 250-base pair fragment which confers cardiac-specific expression. J Biol Chem 264: 18142-18148, 1989.
25. Hoshijima M, Sah VP, Wang Y, Chien KR, and Brown JH. The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase. J Biol Chem 273: 7725-7730, 1998.
26. Huang WY, Aramburu J, Douglas PS, and Izumo S. Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy (Letter). Nat Med 6: 482-483, 2000.
27. Huang WY, Chen JJ, Shih N, and Liew CC. Multiple muscle-specific regulatory elements are associated with a DNase I hypersensitive site of the cardiac beta-myosin heavy-chain gene. Biochem J 327: 507-512, 1997.
28. Karns LR, Kariya K, and Simpson PC. M-CAT, CArG, and Sp1 elements are required for alpha 1-adrenergic induction of the skeletal alpha-actin promoter during cardiac myocyte hypertrophy. Transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth. J Biol Chem 270: 410-417, 1995.
29. Kemp PR and Metcalfe JC. Four isoforms of serum response factor that increase or inhibit smooth-muscle-specific promoter activity. Biochem J 345: 445-451, 2000.
30. Klamut HJ, Gangopadhyay SB, Worton RG, and Ray PN. Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene. Mol Cell Biol 10: 193-205, 1990.
31. Lijnen P and Petrov V. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. J Mol Cell Cardiol 31: 949-970, 1999.
32. Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, Badesch DB, Groves BM, Gilbert EM, and Bristow MR. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. J Clin Invest 100: 2315-2324, 1997.
33. Lu XG, Azhar G, Liu L, Tsou H, and Wei JY. SRF binding to SRE in the rat heart: influence of age. J Gerontol A Biol Sci Med Sci 53: B3-B10, 1998.
34. Mercadier JJ, Lompre AM, Duc P, Boheler KR, Fraysse JB, Wisnewsky C, Allen PD, Komajda M, and Schwartz K. Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest 85: 305-309, 1990.
35. Miwa T and Kedes L. Duplicated CArG box domains have positive and mutually dependent regulatory roles in expression of the human alpha-cardiac actin gene. Mol Cell Biol 7: 2803-2813, 1987.
36. Moalic JM, Charlemagne D, Mansier P, Chevalier B, and Swynghedauw B. Cardiac hypertrophy and failure - a disease of adaptation. Modifications in membrane proteins provide a molecular basis for arrhythmogenicity. Circulation 87, Suppl 5: IV21-IV26, 1993.
37. Molkentin JD, Jobe SM, and Markham BE. Alpha-myosin heavy chain gene regulation: delineation and characterization of the cardiac muscle-specific enhancer and muscle-specific promoter. J Mol Cell Cardiol 28: 1211-1225, 1996.
38. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, and Oison EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228, 1998.
39. Morano I. Tuning the human heart molecular motors by myosin light chains. J Mol Med 77: 544-555, 1999.
40. Muscat GE, Gustafson TA, and Kedes L. A common factor regulates skeletal and cardiac alpha-actin gene transcription in muscle. Mol Cell Biol 8: 4120-4133, 1988.
41. Nakao K, Minobe W, Roden R, Bristow MR, and Leinwand LA. Myosin heavy chain gene expression in human heart failure. J Clin Invest 100: 2362-2370, 1997.
42. Olson TM, Michels W, Thibodeau SN, Tai YS, and Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280: 750-752, 1998.
43. Papadopoulos N and Crow MT. Transcriptional control of the chicken cardiac myosin light-chain gene is mediated by two AT-rich cis-acting DNA elements and binding of serum response factor. Mol Cell Biol 13: 6907-6918, 1993.
44. Parker TG. Molecular biology of cardiac growth and hypertrophy. Herz 18: 245-255, 1993.
45. 2+-ATPase during progression of left ventricular hypertrophy. Am J Physiol Heart Circ Physiol 272: H2416-H2424, 1997.
46. Robbins J. Altering cardiac function via transgenesis. A nuts and bolts approach. Trends Cardiovasc Med 7: 185-191, 1997.
47. Sadoshima J and Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J 12: 1681-1692, 1993.
48. Sartorelli V, Webster KA, and Kedes L. Muscle-specific expression of the cardiac alpha-actin gene requires MyoD1, CArG-box binding factor, and Sp1. Genes Dev 4: 1811-1822, 1990.
49. Schwartz K, Carrier L, Lompre AM, Mercadier JJ, and Boheler KR. Contractile proteins and sarcoplasmic reticulum calcium-ATPase gene expression in the hypertrophied and failing heart. Basic Res Cardiol 87: 285-290, 1992.
50. Spencer JA, Baron MH, and Olson EN. Cooperative transcriptional activation by serum response factor and the high mobility group protein SSRPl. J Biol Chem 274: 15686-15693, 1999.
51. Spencer JA and Misra RP. Expression of the serum response factor gene is regulated by serum response factor binding sites. J Biol Chem 271: 16535-16543, 1996.
52. Stein B, Bartel S, Kirchhefer U, Kokott S, Krause EG, Neumann J, Schmitz W, and Scholz H. Relation between contractile function and regulatory cardiac proteins in hypertrophied hearts. Am J Physiol Heart Circ Physiol 270: H2021-H2028, 1996.
53. Takahashi T, Schunkert H, Isoyama S, Wei JY, Nadal-Ginard B, Grossman W, and Izumo S. Age-related differences in the expression of proto-oncogene and contractile protein genes in response to pressure overload in the rat myocardium. J Clin Invest 89: 939-946, 1992.
54. Takai E, Akita H, Shiga N, Kanazawa K, Yamada S, Terashima M, Matsuda Y, Iwai C, Kawai K, Yokota Y, and Yokoyama M. Mutational analysis of the cardiac actin gene in familial and sporadic dilated cardiomyopathy. Am J Med Genet 86: 325-327, 1999.
55. Thuerauf DJ, Arnold ND, Zechner D, Hanford DS, DeMartin KM, McDonough PM, Prywes R, and Glembotski CC. p38 Mitogen-activated protein kinase mediates the transcriptional induction of the atrial natriuretic factor gene through a serum response element. A potential role for the transcription factor ATF6. J Biol Chem 273: 20636-20643, 1998.
56. Tsou H, Azhar G, Lu XG, Kovacs S, Peacocke M, and Wei JY. Age-associated changes in basal c-fos transcription factor binding activity in rat hearts. Exp Cell Res 229: 432-437, 1996.
57. Vikstrom KL, Bohlmeyer T, Factor SM, and Leinwand LA. Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. Circ Res 82: 773-778, 1998.
58. Welikson RE, Buck SH, Patel JR, Moss RL, Vikstrom KL, Factor SM, Miyata S, Weinberger HD, and Leinwand LA. Cardiac myosin heavy chains lacking the light chain binding domain cause hypertrophic cardiomyopathy in mice. Am J Physiol Heart Circ Physiol 276: H2148-H2158, 1999.
59. Whitmarsh AJ, Shore P, Sharrocks AD, and Davis RJ. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269: 403-407, 1995.